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Abstract
In Ukraine, cardiovascular diseases are the leading cause of morbidity and rank second among primary diseases.
Nowadays the most common cardiovascular disease is coronary artery disease that accounts for 33.7% of total
cardiovascular pathology cases.
The objective of the research was to study clinical manifestations and indicators of endothelial function and
immune-inflammatory response in the patients with coronary artery disease, heart failure with preserved left
ventricular ejection fraction depending on affected coronary artery number.
Materials and methods. The study included 62 patients with chronic coronary artery disease, heart failure
with preserved left ventricular ejection fraction who underwent coronary artery stenting. Among the examined
patients, males prevailed – 52 (83.9%) individuals. All the patients were randomized according to the number of
the affected coronary arteries and divided into two groups. Clinical manifestations were studied; the patients’
quality of life was assessed; the functional state of the myocardium was determined according to the six-minute
walk test; the indicators of endothelial dysfunction were analyzed by endothelin-l level; the indicators of immune
inflammatory response were analyzed by serum levels of C-reactive protein and tumor necrosis factor.
Results. In the examined patients, the clinical course did not depend on the number of the affected coronary
arteries; however, to reduce the incidence of cardiac pain, the patients with multivessel coronary artery disease
received 2±0.1 extra nitroglycerin tablets.
Conclusions. Quality of life and physical well-being were better in the patients with single-vessel coronary
artery disease (p<0.05). Myocardial functional reserves were lower in the patients with multivessel coronary
artery disease (p<0.05), while the intensity of immune inflammation and endothelial dysfunction reduced in
case of multivessel coronary artery disease that confirmed a strong correlation between the indicators of tumor
necrosis factor and endothelin-l.
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Problem statement and analysis of
the latest research
According to research studies, over the past decade,
there has been a tendency for an increase in cardio-
vascular disease incidence. Cardiovascular diseases
account for approximately 40% of all deaths in most
European countries. In Ukraine, they account for
63.0% of the total mortality [5].
In most developed countries, coronary artery
disease (CAD) is one of the leading causes of mor-
bidity, temporary and permanent disability, as well
as mortality [2, 9]. The clinical course of CAD is
accompanied by anginal attacks, low exercise toler-
ance, limited self-care activities, decreased psycho-
emotional well-being that impair quality of life
(QoL) in the patients [10, 14]. The World Health
Organization defines ”Quality of Life” as an indi-
vidual’s perception of their position in life in the
context of the culture and value systems in which
they live and in relation to their goals, expectations,
standards and concerns [7, 17]. In modern medicine,
the term ”health-related quality of life” (HRQoL) is
most commonly used. When assessing HRQoL, the
patient’s complaints associated with the disease are
considered that allows determining the effect of the
disease and treatment on the patient’s psychological,
emotional and social status [16].
According to most researchers, alongside with
stress factor and impaired lipid metabolism, im-
mune inflammatory response which results in en-
dothelial dysfunction (ED) leading to acute coro-
nary events plays a significant role in CAD develop-
ment as well. According to research studies, a high
level of inflammatory markers, namely C-reactive
protein (CRP) in healthy individuals serves as a
risk factor for developing future cardiovascular ac-
cidents [1, 15]. Among the patients with unstable
angina, elevated CRP level was observed in 70%
of the cases. Immune activation in the vessel wall,
regardless of CAD etiology, was found to be main-
tained by a number of mechanisms including cy-
tokine hyperproduction, increase in autoantibody
concentration and impairment of cell-mediated im-
munity [11, 12]. Among cytokines, tumor necrosis
factor-α (TNF-α) plays an important role [13].
ED limits vasodilator reserves, contributes to
increased risk of blood clotting, thrombosis, sys-
temic embolism, activation of immunocompetent
cells and mediators of cytokine cascade that initi-
ate systemic inflammatory response [6]. ED plays
a certain role in the initiation and progression of
atherosclerotic plaques and myocardial ischemia,
as well as in left ventricular (LV) remodeling and
progression of CAD and heart failure. Studies have
demonstrated that the clinical condition of the pa-
tients with CAD often correlated with overproduc-
tion of endothelin-l (ET-1) [8].
The objective of the research was to study
clinical manifestations and indicators of endothe-
lial function and immune-inflammatory response in
the patients with chronic CAD, heart failure with
preserved LV ejection fraction (EF) depending on
affected coronary artery (CA) number; to study dy-
namics of cardiac pain and to assess QoL in the
patients with chronic CAD, heart failure with pre-
served LVEF depending on affected CA number;
to analyze exercise tolerance in the patients with
chronic CAD and to determine the interdependent
relationship between systemic immune inflamma-
tory response, ED and the number of the affected
CA.
1. Materials and Methods
The study included 62 patients with chronic CAD,
heart failure with preserved LVEF who underwent
CA stenting. The study was carried out in the Cardi-
ology Center of Ivano-Frankivsk Central City Hos-
pital; regular medical check-ups were carried out
in municipal polyclinics. Among the examined pa-
tients, males prevailed – 52 (83.9%) individuals.
The average age was 61.2±1.2 years. The control
group included 15 (12 males and 3 females) appar-
ently healthy individuals with the average age of
60±0.7 years. All the patients were randomized ac-
cording to the number of the affected CA, the results
of coronary angiography (CAG), the type of treat-
ment. Among 62 patients, single-vessel coronary
artery disease (CAD) was diagnosed in 16 patients,
while two-vessel or multivessel CAD was found in
46 patients. In 54 (87.1%) patients, second-degree
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or third-degree arterial hypertension stage II-III was
observed.
All the patient underwent CAG. The indications
for CAG included chronic coronary insufficiency
(previous myocardial infarction), heart failure with
preserved LVEF, primary angina, unstable (progres-
sive) angina, post-infarction angina, CAG for ver-
ification of CAD diagnosis [3]. There were used
the Infinix CC-i/FPD angiographs manufactured
by Toshiba Medical Systems Corporation (Japan).
CAG procedures were performed via radial artery
access.
All the patients underwent a complete clini-
cal examination in accordance with the Unified
Clinical Protocol of Primary, Secondary (Special-
ized) and Tertiary (Highly Specialized) Medical
Care approved by the Order of Ministry of Health
of Ukraine of March 02, 2016, No 152 ”Chronic
Coronary Artery Disease” (updated September 23,
2016, No 994), the recommendations of the Eu-
ropean Society of Cardiology (ESC) ”ESC Guide-
lines for the Diagnosis and Treatment of Acute and
Chronic Heart Failure 2012” and the guidelines of
the Ukrainian Heart Failure Association (2017).
During clinical examination, the incidence and
symptoms of cardiac pain and a weekly dose of
nitroglycerin were considered. To assess QoL, there
was used a HRQoL questionnaire for patients with
heart failure – the Minnesota Living with Heart
Failure Questionnaire (MLHFQ) that concerns a
variety of physical aspects of the patient’s life as
well as emotional and social factors, the need for
treatment (Rector TS et al., 1987). The MLHFQ
contains 21 questions specific to heart failure rated
on a scale from 0 (very high QoL) to 105 (very low
QoL).
To assess New York Heart Association (NYHA)
FC of CAD in cardiac patients, the six-minute walk
test (6 MWT) was used. The 6 MWT entails mea-
surement of distance walked over a span of 6 min-
utes. The patient was offered to walk as far as
possible for 6 minutes at the rate of one step per
second.
Serum concentration of ET-1 was determined
by means of two-step enzyme-linked immunosor-
bent assay (ELISA) using commercial ELISA kit
BI-20052 Endothelin (Biomedica, Austria), serum
level of TNF-α was measured by means of reagent
kit ”ProCon TNF-α” (Protein Contour, Russian
Federation), respectively using an analyzer Stat-Fax
210200 (Awareness Technology, Inc, USA). Serum
level of CRP was determined by a latex aggluti-
nation test using reagent kit ”Granum” (Ukraine)
according to the method proposed by the manufac-
turer.
To objectively assess the reliability of the re-
search results, variational statistical analysis of the
results obtained was conducted on a Pentium II
PC using the Statistica 8.0 software package and
Microsoft Excel statistical functions.
2. Results and Discussion
Single-vessel CAD confirmed by CAG was found
in 16 (25.8%) patients, while multivessel CAD
was observed in 46 (74.2%) patients – there were
34 (73.9%) patients with two-vessel CAD and 12
(26.1%) patients with three-vessel CAD.
According to CAG, 120 CA were affected. In
general, the anterior interventricular branch (AIB)
of the left coronary artery (LCA), the AIB of the
right coronary artery (RCA) and the left circumflex
artery (LCX) were most commonly affected – in
48 (40.0%), 33 (27.5%), 29 (24.2%) cases, respec-
tively; the diagonal branch (DB) of the LCA and
intermediate CA were rarely affected – in 7 (5.8%)
and 3 (2.5%) cases, respectively (Fig. 1).
After analysis of the cases with single-vessel
CAD, the AIB of the LCA was found to be affected
in 50.0% of the cases, the RCA – in 31.3% of the
cases and the LCX – in 18.7% of the cases.
Multivessel CAD was usually accompanied by
damage to the AIB of the LCA in combination
with damage to the LCX in 34.8% of the patients;
damage to the AIB of the LCA in combination
with damage to the RCA in 21.7% of the patients;
damage to the RCA in combination with damage
to the LCX in 13.1% of the patients; damage to the
AIB of the LCA in combination with damage to the
DB of the LCA in 4.3% of the cases; damage to
the AIB of the LCA in combination with damage
to the RCA and the LCX in 8.7% of the cases;
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Figure 1. Structure of CA damage in the patients with chronic CAD, heart failure with preserved LVEF
damage to the AIB of the LCA in combination with
damage to the RCA and the DB of the LCA in
10.9% of the patients; damage to the AIB of the
LCA in combination with damage to the RCA and
the intermediate CA in 6.5% of the patients.
Among 62 patients suffering from heart failure
with preserved LVEF, single-vessel CAD was di-
agnosed in 25.8% of the cases, while multivessel
CAD was found in 74.2% of the cases. After CAG,
all the patients were divided according to the num-
ber of the affected CA. Heart failure with preserved
LVEF was diagnosed in 25.8% of the patients with
single-vessel CAD and 74.2% of the patients with
multivessel CAD.
The analysis of the clinical course of the disease
showed that anginal attack manifested itself as pain
syndrome, namely burning pain in 66.1% of the
patients, squeezing pain in 21.0% of the patients,
stabbing pain in 12.9% of the patients. Retroster-
nal pain was accompanied by pressure sensation in
69.1% of the cases, shortness of breath – in 64.5%
of the cases, nausea – in 29.4% of the cases, vomit-
ing – in 12.9% of the cases, palpitation – in 85.5%
of the cases, dizziness – in 72.6% of the cases. Pain
radiation to the left shoulder, arm, jaw, neck and
face was observed in all the patients.
The patients with single-vessel CAD addition-
ally received nitroglycerin at a dose of 11.8±0.35
Table 1. Results of QoL assessment in the
patients with chronic CAD, heart failure with
preserved LVEF depending on affected CA number
according to the MLHFQ, points, (M±m).
Affected coronary
artery number
Patients, n = 62
Single-vessel CAD, n = 16 40.3±0.94*
Multivessel CAD, n = 46 62.1±1.37
Note: * - statistically significant difference between
single-vessel and multivessel CAD, p<0.001.
tablets per week, while in the patients with multi-
vessel CAD, the dose of nitroglycerin increased to
13.9±0.24 tablets per week (p<0.001). Thus, the
dose of nitroglycerin depended on the number of
CA affected.
According to the MLHFQ, in the patients with
multivessel CAD, QoL was 35.1% lower as com-
pared to the patients with single-vessel CAD
(p<0.001) (Table 1).
According to the results of assessing different
aspects of QoL by means of the MLHFQ, in the
patients with multivessel CAD, the physical ML-
HFQ score was 35.1% higher as compared to the
patients with single-vessel CAD (p<0.001) and
the emotional MLHFQ score was 13.6% higher
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Table 2. Results of assessing various QoL aspects
in the patients with chronic CAD, heart failure with
preserved LVEF depending on affected CA number
according to the MLHFQ, points, (M±m).
QoL aspect
Patients,
n = 62
Single-vessel
CAD,
Multivessel
CAD,
n = 16 n = 46
Physical 15.5±0.24 23.9±0.63*
Emotional 12.1±0.24 14.0±0.38*
Social 3.9±0.19 5.3±0.11*
Therapeutic 10.2±0.15 12.9±0.29*
Note: * - statistically significant difference between
single-vessel and multivessel CAD, p<0.001.
as compared to the patients with single-vessel CAD
(p<0.001). By social aspect, in the patients with
multivessel CAD, the MLHFQ score was 26.4%
higher as compared to the patients with single-vessel
CAD (p<0.001). In the patients with multivessel
CAD, the therapeutic aspect was 20.9% higher as
compared to the patients with single-vessel CAD
(p<0.001) (Table 2).
To analyze exercise tolerance, the 6 MWT was
used. Its results showed that before treatment, the
median distance walked was 200 m; the test had
to be interrupted due to the deterioration of the pa-
tient’s condition. According to the functional test,
half of the patients walked more than 200 m. Re-
duced exercise tolerance was observed in all the
patients. Thus, the patients with single-vessel CAD
walked 251.5±8.41 m, while the patients with mul-
tivessel CAD walked 219.2±10.58 m (p<0.05).
In healthy individuals, the 6 MWT distance was
558.7±2.41 m, that exceeded that in the patients
with single-vessel CAD and multivessel CAD by
2.2. and 2.5 times, respectively (p<0.001) (Fig. 2).
The analysis of ED as an independent risk marker
of unfavorable clinical course of cardiovascular dis-
ease deserves special attention. In the patients with
single-vessel CAD, serum concentration of ET-1
was 1.6 times higher as compared to healthy indi-
viduals and 1.7 times higher as compared to the
patients with multivessel CAD (p<0.001). A sig-
nificant difference in the indicators of ET-1 was
observed depending on the number of the affected
CA. In the patients with multivessel CAD, the indi-
cator of ET-1 exceeded this indicator in the patients
with single-vessel CAD by 8.6% (p<0.05).
There was determined a strong correlation be-
tween inflammatory processes and damage to the
vessel wall. TNF which is activated in cell apoptosis
alters vascular endothelium through the enhance-
ment of low-density lipoprotein (LDL) peroxida-
tion that results in the increased production of free
radicals with cytotoxic effect. During the patients’
examination, TNF-α activity was found to depend
on the number of the affected CA. In single-vessel
CAD, TNF-α level exceeded normal limits by 4.2
times, while in multivessel CAD, TNF-α level ex-
ceeded normal limits by 4.9 times (p<0.001). In the
patients with multivessel CAD, TNF-α production
was 14.4% higher as compared to the patients with
single-vessel CAD.
In the patients with single-vessel CAD, the level
of systemic inflammation marker, namely CRP was
3.6 times higher than that in healthy individuals;
in the patients with multivessel CAD, it was 4.9
times higher as compared to healthy individuals
(p<0.001). The increase in serum CRP level de-
pended on the number of the affected CA. Thus,
in the patients with multivessel CAD, serum CRP
level exceeded that in the patients with single-vessel
CAD by 26.4% (p<0.05) (Table 3).
Since immune inflammation plays an important
role in the formation of ED and acute coronary
events, we have studied the interdependent rela-
tionship between the main components of immune
inflammation, namely TNF- α and ET-1 as a marker
of endothelial abnormalities depending on the num-
ber of the affected CA. In the patients suffering from
heart failure with preserved LVEF in case of one-
vessel and multivessel CAD, a strong correlation
between these indicators was determined (r=0.92,
p<0.001 and r=0.93, p<0.001) (Fig. 3, Fig. 4).
Chronic CAD is a disease deserving special
attention since late diagnosis and irrational treat-
ment may result in serious cardiovascular events
such as myocardial infarction, heart rhythm dis-
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Figure 2. A 6 MWT distance depending on the number of the affected CA.
Notes:
p1, p2 – statistical significance of difference in the indicator between healthy individuals and patients with
single-vessel and multivessel CAD;
p3 – statistical significance of difference in the indicator between the patients with single-vessel CAD and those
with multivessel CAD.
Table 3. Characteristics of ED and systemic immune-inflammatory activity in the patients with chronic
CAD, heart failure with preserved LVEF, (M±m).
Indicators
Patients, n = 62
Healthy individuals, Single-vessel CAD, Multivessel CAD,
n = 15 n = 16 n = 46
1 2 3
ET-1, ng/l 5.4±0.24
8.5±0.19 9.3±0.21
p1-2<0.001 p1-3<0.001
p2-3<0.05
TNF-α , pg/ml 25.6±2.37
108.1±3.58 126.3±4.82
p1-2<0.001 p1-3<0.001
p2-3<0.05
CRP, g/l 2.4±0.18
8.7±0.42 11.0±0.91
p1-2<0.001 p1-3<0.001
p2-3<0.01
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Figure 3. Correlation between TNF-alpha and ET-1 in the patients with chronic CAD, heart failure with
preserved LVEF, single-vessel CAD.
Figure 4. Correlation between TNF-alpha and ET-1 in the patients with chronic CAD, heart failure with
preserved LVEF, multivessel CAD.
orders, CAD destabilization and increase in FC
and chronic heart failure decompensation which,
in turn, are associated with a high risk of fatal out-
comes. The question of an individual approach and
rational treatment of a particular patient consider-
ing the pathogenesis, clinical course and progres-
sion of this pathology remains open. Therefore,
the study of the dynamics of the indicators of clini-
cal condition, immunological processes and ED of
chronic CAD, heart failure with preserved LVEF in
the patients undergoing high-quality combination
treatment, namely myocardial revascularization and
standard long-term pharmacotherapy with the addi-
tion of f-channel inhibitor of the sinoatrial node of
cardiac conduction system is promising.
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